Baxter International (BAX) Liabilities and Shareholders Equity (2009 - 2026)

Baxter International (BAX) has 18 years of Liabilities and Shareholders Equity data on file, last reported at $19.8 billion in Q1 2026.

• Liabilities and Shareholders Equity for Q1 2026 came in at $19.8 billion, down 6.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $82.0 billion (down 18.05% YoY), and the FY2025 annual result was $20.1 billion, down 22.21% from the prior year.
• Liabilities and Shareholders Equity fell to $19.8 billion in Q1 2026 per BAX's latest filing, from $20.1 billion in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $32.7 billion in Q1 2022 and troughed at $19.8 billion in Q1 2026.
• A 5-year average of $26.2 billion and a median of $27.8 billion in 2024 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2022 and 2025: Liabilities and Shareholders Equity soared 68.07% in 2022, then decreased 23.33% in 2025.
• A 5-year view of Liabilities and Shareholders Equity shows it stood at $28.3 billion in 2022, then slipped by 0.04% to $28.3 billion in 2023, then retreated by 8.82% to $25.8 billion in 2024, then dropped by 22.21% to $20.1 billion in 2025, then slipped by 1.04% to $19.8 billion in 2026.
• Business Quant data shows BAX's Liabilities and Shareholders Equity at $19.8 billion in Q1 2026, $20.1 billion in Q4 2025, and $21.1 billion in Q3 2025.